Nucl Med Mol Imaging.
2025 Apr;59(2):95-99. 10.1007/s13139-024-00903-z.
Reflections on the 2024 KTA Guideline and the Role of Radioiodine Therapy in Differentiated Thyroid Cancer
- Affiliations
-
- 1Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea
- 2Department of Nuclear Medicine, Seoul National University Boramae Medical Center, Seoul, Korea
- 3Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2567351
- DOI: http://doi.org/10.1007/s13139-024-00903-z
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part‑I
- Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II
- Updates in the 2024 Korean Thyroid Association Clinical Practice Guidelines for Differentiated Thyroid Cancer: from Diagnosis to Initial Treatment
- Low Dose versus High Dose Radioiodine Therapy
- Recent Advances in Radioiodine Therapy for Thyroid Cancer
